Topics

Beckman Coulter, Inc. Strategy, SWOT and Corporate Finance Report [Published by Marketline] Prices from USD $175

17:30 EDT 13 Aug 2019 | BioPortfolio Reports

Beckman Coulter, Inc. Strategy, SWOT and Corporate Finance Report


Summary


Beckman Coulter, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.


Key Highlights


Beckman Coulter, Inc. Beckman Coulter or the company' is an indirect, whollyowned subsidiary of Danaher Corporation Danaher. The company is engaged in the design, manufacture and marketing of biomedical testing instrument systems, tests and supplies in the US, Canada, Latin America, Europe, Asia Pacific, the Middle East and Africa. The company is headquartered in Brea, California.


Scope


Detailed information on Beckman Coulter, Inc. required for business and competitor intelligence needs

A study of the major internal and external factors affecting Beckman Coulter, Inc. in the form of a SWOT analysis

An indepth view of the business model of Beckman Coulter, Inc. including a breakdown and examination of key business segments

Intelligence on Beckman Coulter, Inc.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Beckman Coulter, Inc., such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends


Reasons to buy


Gain understanding of Beckman Coulter, Inc. and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Beckman Coulter, Inc. as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Beckman Coulter, Inc.'s business structure, strategy and prospects.

Original Article: Beckman Coulter, Inc. Strategy, SWOT and Corporate Finance Report [Published by Marketline] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "Beckman Coulter, Inc. Strategy, SWOT and Corporate Finance Report [Published by Marketline] Prices from USD $175"

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...